Title AIE Featured Inorganic-Organic Core@Shell Nanoparticles for High-Efficiency siRNA Delivery and Real-Time Monitoring
Authors He, Xuewen
Yin, Feng
Wang, Dongyuan
Xiong, Ling-Hong
Kwok, Ryan T. K.
Gao, Peng Fei
Zhao, Zheng
Lam, Jacky W. Y.
Yong, Ken-Tye
Li, Zigang
Tang, Ben Zhong
Affiliation Hong Kong Univ Sci & Technol, Chinese Natl Engn Res Ctr Tissue Restorat & Recon, Div Life Sci, Dept Chem,Hong Kong Branch,Inst Adv Study,Kowloon, Clear Water Bay, Hong Kong, Peoples R China
Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China
Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, State Key Lab Chem Oncogen,Key Lab Chem Genom, Shenzhen 518055, Peoples R China
HKUST Shenzhen Res Inst, Shenzhen 518057, Peoples R China
Shenzhen Ctr Dis Control & Prevent, Shenzhen 518055, Peoples R China
Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore
South China Univ Technol, State Key Lab Luminescent Mat & Devices, SCUT HKUST Joint Res Lab, Ctr Aggregat Induced Emiss, Guangzhou 510640, Guangdong, Peoples R China
Keywords Aggregation-induced emission (AIE)
nanocarrier
siRNA
real-time
apoptosis
Issue Date 2019
Publisher NANO LETTERS
Abstract RNA interference (RNAi) is demonstrated as one of the most powerful technologies for sequence-specific suppression of genes in disease therapeutics. Exploration of novel vehicles for small interfering RNA (siRNA) delivery with high efficiency, low cytotoxicity, and self-monitoring functionality is persistently pursued. Herein, by taking advantage of aggregation-induced emission luminogen (AIEgen), we developed a novel class of Ag@AIE core@shell nanocarriers with regulable and uniform morphology. It presented excellent efficiencies in siRNA delivery, target gene knockdown, and cancer cell inhibition in vitro. What's more, an anticancer efficacy up to 75% was achieved in small animal experiments without obvious toxicity. Attributing to the unique AIE properties, real-time intracellular tracking of siRNA delivery and long-term tumor tissue imaging were successfully realized. Compared to the commercial transfection reagents, significant improvements were obtained in biocompatibility, delivery efficiency, and reproducibility, representing a promising future of this nanocarrier in RNAi-related cancer therapeutics.
URI http://hdl.handle.net/20.500.11897/549440
ISSN 1530-6984
DOI 10.1021/acs.nanolett.8b04677
Indexed SCI(E)
EI
Appears in Collections: 深圳研究生院待认领

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.